glp-1 news 2025 october 16 Perspectives from employers on the costs and issues associated with covering agonists for weight loss Monster of 2025: GLP-1 Ads

It also says thyroid function and kidney function measured by eGFR should be assessed at baseline and monitored periodically during treatment

If you do, the next step is a conversation with a licensed prescriber ideally one familiar with obesity medicine who can evaluate your full medical history, discuss benefits and risks, and determine whether therapy is appropriate and how insurance coverage looks for your specific plan

Shreya Jain, a 45-year-old individual, presented with visible signs of skin aging, reduced skin elasticity, and delayed healing following minor dermatological procedures

10.1111/jpn.12959 J

Reduced Efficacy and Food Noise Because the medication levels drop significantly by day 10, many patients report the return of food noisethe intrusive, constant thoughts about eating

It is a metabolic strategy with measurable outcomes